Intracellular cholesterol and phospholipid trafficking: Comparable mechanisms in macrophages and neuronal cells

Neurochemical Research

Volumn 26, Issue 8-9, 2001, Pages 1045-1068

  Schmitz, Gerd ^a   Orsó, Evelyn ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cholesterol; Macrophages; Membrane traffic; Monocytes; Neuronal cells; Phospholipids

Indexed keywords

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL METABOLISM; CHOLESTEROL TRANSPORT; COMPARATIVE STUDY; LIPID TRANSPORT; MACROPHAGE ACTIVATION; MONOCYTE; NERVE CELL; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN PROCESSING; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; HUMANS; MACROPHAGES; NEURONS; PHOSPHOLIPIDS;

EID: 0034753170     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012357106398     Document Type: Article

References (208)

1. Physical properties and functional roles of lipids in membranes
2. Lipid assembly into cell membranes
3. Intracellular cholesterol transport
4. Functional rafts in cell membranes
5. Caveolins and cellular cholesterol balance
6. Lipid rafts and signal transduction
7. The synthesis and transport of lipids for axonal growth and nerve regeneration
8. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane
9. Prominin: A story of cholesterol, plasma membrane protrusions and human pathology
10. The making and breaking of the endoplasmic reticulum
11. Cell cycle maintenance and biogenesis of the Golgi complex
12. Gut thoughts on the Golgi complex
13. Structure, assembly and secretion of lipoproteins
14. Dynamics of lipoprotein transport in the human circulatory system
15. Neurosteroids: Biosynthesis and function of these novel neuromodulators
16. Membrane dynamics in endocytosis: Structure-function relationship
17. Role of membrane organization and membrane domains in endocytic lipid trafficking
18. Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-Golgi network
19. Lipid metabolism and regulation of membrane trafficking
20. Subcellular targeting by membrane lipids
21. ABC transporters in cellular lipid trafficking
22. Specific proteins are required to translocate phosphatidylcholine bidirectionally across the endoplasmic reticulum
23. Enrichment of acyl coenzyme A:cholesterol O-acyltransferase near trans-golgi network and endocytic recycling compartment
24. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins
25. Receptor mediated endocytosis: Concepts emerging from the LDL receptor system
26. Macrophage foam cells and atherosclerosis
27. Cholesterol metabolism in the brain
28. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells
29. Lipid translocation across the plasma membrane of mammalian cells
30. Cellular organelles: How lipids get there, and back
31. Role for Drs2p, a P-type ATPase and potential aminophospholipid translocase, in yeast late Golgi function
32. Identification of three new members of the phospholipid scramblase gene family
33. Recent progress in P-glycoprotein research
34. Overexpression of MDRI in an intestinal cell line results in increased cholesterol uptake from micelles
35. β-amyloid efflux mediated by p-glycoprotein
36. ABCG1 (ABC8), the human homolog of the drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
37. Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles
38. 3 inhibit spreading of human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42
39. Neuronal polarity: Essential role of protein-lipid complexes in axonal sorting
40. Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes
41. Establishment of neuronal polarity: Lessons from cultured hippocampal neurons
42. Inhibition of axonal growth by brefeldin A in hippocampal neurons in culture
43. Rho GTPases in growth cone guidance
44. The role of Notch and Rho GTPase signaling in the control of dendritic development
45. Characterization of the regulation of phospholipase D activity in the detergent-insoluble fraction of HL60 cells by protein kinase C and small G-proteins
46. Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells
47. Phospholipase D2: Functional interaction with caveolin in low-density membrane microdomains
48. Role of plasmalemmal caveolae in signal transduction
49. Molecular genetics of the caveolin gene family: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
50. Caveolin-1 expression in Schwann cells
51. Caveolae can be alternative endocytic structures in elicited macrophages
52. Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease
53. A detergent-insoluble membrane compartment contains A-beta in vivo
54. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
55. Genetic defects in postsqualene cholesterol biosynthesis
56. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome
57. X-linked dominant disorders of cholesterol biosynthesis in man and mouse
58. Regulation of gene expression by SREBP and SCAP
59. From cholesterol transport to signal transduction: Low density lipoprotein receptor, very low density lipoprotein receptor, and apolipoprotein E receptor-2
60. Members of the low density lipoprotein receptor family control diverse physiological processes
61. Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: An in situ hybridization study
62. Uptake of lipoproteins for axonal growth of sympathetic neurons
63. Cardiovascular disorders: Atherosclerosis
64. HMG-CoA reductase inhibitor therapy and peripheral neuropathy
65. Peripheral neuropathy and lipid-lowering therapy
66. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
67. Nerve regeneration occurs in the absence of apolipoprotein E in mice
68. Nerve regeneration and cholesterol utilization occur in the absence of apolipoproteins E and A-I in mice
69. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction
70. The reelin receptor apoER2 recruits JNK-interacting proteins-1 and -2
71. 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease
72. 2-macroglobulin associates with β-amyloid peptide and prevents fibril formation
73. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
74. Macrophage scavenger receptors and foam cell formation
75. Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis
76. Metabolism of oxidized LDL by macrophages
77. On the pathogenesis of atherosclerosis: Enzymatic transformation of human low density lipoprotein to an atherogenic moiety
78. Role of mast cells in atherosclerosis
79. + monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36
80. Enhanced macrophage uptake of low density lipoprotein after self-aggregation
81. Degradation of chylomicron remnants by macrophages occurs via phagocytosis
82. Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages
83. Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages
84. Sequestration of acetylated LDL and cholesterol crystals by human monocyte-derived macrophages
85. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI
86. Scavenger receptor BI and cholesterol trafficking
87. The role of the high-density lipoprotein receptor SR-BI in cholesterol metabolism
88. Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester
89. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
90. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain
91. The class B, type I scavenger receptor promotes the selective uptake of high density cholesteryl ethers into caveolae
92. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells
93. Intracellular cholesterol transport
94. Evidence that a neutral cholesteryl ester hydrolase is responsible for the extralysosomal hydrolysis of high-density lipoprotein cholesteryl ester in rat hepatoma cells (Fu5AH)
95. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1
96. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I
97. Comparison of class B scavenger receptors, CD36 and SR-BI, shows that both receptors mediate HDL-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake
98. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats
99. CD36 and atherosclerosis
100. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins
101. Apolipoprotein A-I: Structure - Function relationships
102. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body
103. Structure and function of apolipoprotein A-I and high-density lipoprotein
104. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
105. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
106. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette tarnsporter 1
107. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
108. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abcl-deficient mice
109. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-I
110. Tangier disease and ABCA1
111. Structure, function and regulation of the ABC1 gene product
112. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis
113. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter
114. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages
115. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes in culture
116. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
117. Scavenger receptor class B type I as a modulator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors
118. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides
119. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol
120. Protein kinase C-alpha levels are inversely associated with growth rate in cultured human dermal fibroblasts
121. HDL stimulates phosphorylation of 18 and 80 kDa proteins in cholesterol-loaded human skin fibroblasts
122. High density lipoproteins stimulate mitogen activated protein kinases in human skin fibroblasts
123. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms
124. Activation of phosphatidyl-inositol-specific phospholipase C in response to high density and low density lipoproteins is markedly reduced in cultured fibroblasts from Tangier patients
125. High density and low density lipoprotein-mediated signal transduction in cultured human skin fibroblasts
126. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: Role of the ABCA1 gene mutations
127. Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients
128. Activation of phosphatidylinositol-specific phospholipase C by HDL-associated lysosphingolipid. Involvement in mitogenesis but not in cholesterol efflux
129. Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: Biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages
130. Cholesterol efflux to apolipoprotein A1 involves endocytosis and resecretion in a calcium-dependent pathway
131. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: Stimulation by high density lipoprotein and other agents
132. ++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes
133. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
134. Cholesteryl ester transfer protein in human brain
135. Astroglial localization of cholesteryl ester transfer protein in normal and Alzheimer's disease brain tissues
136. Novel pathways for elimination of cholesterol by extrahepatic formation of side-chain oxidized oxysterols
137. Removal of cholesterol from extrahepatic sources by oxidative mechanisms
138. Contribution of cholesterol 7α-hydroxylase to the regulation of lipoprotein metabolism
139. Plasma 24S-hydroxycholesterol: A peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease
140. Oxysterols and atherosclerosis
141. Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain
142. The pleckstrin homology domain of oxysterol-binding protein recognises a determinant specific to Golgi membranes
143. Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding
144. Purification of oxysterol binding protein from hamster liver cytosol
145. Brefeldin-A renders Chinese hamster ovary cells insensitive to transcriptional suppression by 25-hydroxycholesterol
146. Kes l p shares homology with human oxysterolbinding protein and participates in a novel regulatory pathway for yeast Golgi-derived transport vesicle biogenesis
147. Family of human oxysterol binding protein (OSBP) homologues. A novel member implicated in brain sterol metabolism
148. Genetic defects of intracellular-membrane transport
149. Fatty acyl-coenzyme A is required for budding of transport vesicles from Golgi cisternae
150. Stepwise assembly of functionally active transport vesicles
151. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles
152. CtBP/BARS induces fission of Golgi membranes by acylating lysophosphatidic acid
153. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid
154. Lipids, lipid modification and lipid-protein interaction in membrane budding and fission - Insights from the roles of endophilin A1 and synaptophysin in synaptic vesicle endocytosis
155. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport
156. Lipid trafficking and sorting: How cholesterol is filling gaps
157. Phospholipid transfer proteins and physiological functions
158. Phosphatidylinositol/phosphatidylcholine transfer proteins in yeast
159. Phospholipid metabolism and membrane dynamics
160. Sterol carrier protein-2
161. Sterol carrier protein-2 overexpression enhances sterol cycling and inhibits cholesterol ester synthesis and high density lipoprotein cholesterol secretion
162. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function
163. Characterization of a cytosolic heat-shock protein-caveolin chaperone complex. Involvement in cholesterol trafficking
164. Movement of lipolytic products to mitochondria in brown adipose tissue of young rats: An electron microscope study
165. Transport of fatty acids and monoacylglycerols in white and brown adipose tissue
166. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids
167. Effect of pH on visualization of fatty acids as myelin figures in mouse adipose tissue by freeze-fracture electron microscopy
168. Neuropathy in Tangier disease: A clinicopathologic study and a review of the literature
169. Severe polyneuropathy in Tangier disease mimicking syringomyelia or leprosy. Clinical, biochemical, electrophysiological, and morphological evaluation, including electron microscopy of nerve, muscle, and skin biopsies
170. Tangier disease: A disorder of intracellular membrane traffic
171. Abnormal processing of Golgi elements and lysosomes in Tangier disease
172. Dysregulation of lipid metabolism in Tangier-monocyte derived macrophages
173. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency
174. Niemann-Pick disease type C
175. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo
176. Intracellular cholesterol trafficking: Role of the NPC1 protein
177. Niemann-Pick type C: A disorder of cellular cholesterol trafficking
178. The rab7 GTPase resides on a vesicular compartment connected to lysosomes
179. Rab9 functions in transport between late endosomes and the trans Golgi network
180. Altered expression of caveolin-1 and increased cholesterol in detergent insoluble membrane fractions from liver in mice with Niemann-Pick disease type C
181. Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments
182. Related membrane domains in proteins of sterol sensing and cell signaling provide a glimpse of treasures still buried within the dynamic realm of intracellular metabolic regulation
183. Niemann-Pick C1 disease gene: Homology to mediators of cholesterol homeostasis
184. The structure and function of the Niemann-Pick C1 protein
185. The genomic organization and polymorphism analysis of the human Niemann-Pick C1 gene
186. Localization of Niemann-Pick C1 protein in astrocytes: Implications for neuronal degeneration in Niemann-Pick type C disease
187. Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann-Pick C disease mouse
188. Identification of HE1 as the second gene of Niemann-Pick C disease
189. Alzheimer disease and the frontotemporal dementias: Diseases with cerebral deposition of fibrillar proteins
190. Regulation of APP cleavage by α-, β- and γ- secretases
191. Nicastrin modulates presenilin-mediated notch/g1p1 signal transduction and βAPP processing
192. A partner for presenilin
193. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease
194. Apolipoprotein E and atherosclerosis
195. Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses
196. Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells
197. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
198. Apolipoprotein E polymorphism and atherosclerosis: Association of the ε4 allele with defects in the internal elastic lamina
199. Enhanced upregulation of the Fc gamma receptor Illa (CD16a) during in vitro differentiation of ApoE4/4 monocytes
200. Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia
201. A more mature phenotype of blood mononuclear phagocytes is induced by fluvastatin treatment in hypercholesterolemic patients with coronary heart disease
202. + blood monocytes is expanded in sepsis patients
203. Generalized immune activation in pulmonary tuberculosis: Co-activation with HIV infection
204. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: Differential response to in vivo administration of rhM-CSF or rhGM-CSF
205. + monocytes in patients with cancer: Spontaneous elevation and pharmacologic induction by recombinant human macrophage colony-stimulating factor
206. Is the apoE4 allele an independent predictor of coronary events?